| Mood disorders | Neurotic, stress-related and somatoform disorders | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | N | Mean (sd) annual consultations | GEE IRR (95% CI)2 | GEE IRR (95% CI)2 | GEE IRR (95% CI)3 | N | Mean (sd) annual consultations | GEE IRR (95% CI)2 | GEE IRR (95% CI)2 | GEE IRR (95% CI)3 |
Majority | 50,334 | 3.37 (4.67) | 1.004 | Â | Â | 49,140 | 3.05 (4.52) | 1.005 | Â | Â |
Nordics | 877 | 3.44 (4.17) | 1.00 (0.98–1.02) | 1.04 (1.01–1.08) | 1.05 (1.01–1.08) | 748 | 2.83 (3.95) | 0.98 (0.95–1.01) | 0.98 (0.95–1.02) | 0.98 (0.95–1.02) |
Western- Europe (etc) | 714 | 3.64 (5.19) | 1.02 (0.99–1.04) | 1.06 (1.02–1.10) | 1.07 (1.03–1.12) | 528 | 3.04 (3.81) | 1.01 (0.98–1.03) | 1.01 (0.97–1.04) | 1.01 (0.97–1.05) |
EU Eastern Europe | 570 | 3.11 (4.01) | 0.98 (0.96–1.01) | 1.02 (0.99–1.07) | 1.04 (0.99–1.08) | 515 | 2.89 (4.16) | 0.98 (0.95–1.02) | 0.99 (0.95–1.03) | 0.99 (0.95–1.03) |
Non-EU Eastern Europe | 904 | 2.67 (3.50) | 0.95 (0.92–0.67) | 0.98 (0.95–1.02) | 0.99 (0.96–1.03) | 991 | 2.66 (3.31) | 0.97 (0.95–0.99) | 0.97 (0.94–1.00) | 0.97 (0.94–1.01) |
Middle East / North Africa | 1438 | 2.74 (3.38) | 0.95 (0.94–0.97) | 0.99 (0.96–1.03) | 0.99 (0.96–1.03) | 1476 | 2.79 (3.47) | 0.98 (0.96–0.99) | 0.98 (0.95–1.02) | 0.99 (0.95–1.02) |
Sub-Saharan Africa | 420 | 2.52 (3.96) | 0.92 (0.88–0.95) | 0.96 (0.91–1.01) | 0.97 (0.92–1.02) | 529 | 2.68 (3.99) | 0.95 (0.92–0.98) | 0.97 (0.93–1.01) | 0.97 (0.93–1.01) |
South Asia | 585 | 2.81 (3.63) | 0.96 (0.93–0.98) | 1.006 |  | 643 | 2.96 (3.97) | 0.99 (0.97–1.02) | 1.006 | 1.006 |
East/ South East Asia | 532 | 2.72 (3.90) | 0.95 (0.92–0.98) | 0.99 (0.95–1.03) | 0.99 (0.95–1.04) | 422 | 2.54 (3.69) | 0.96 (0.92–0.99) | 0.96 (0.91–1.00) | 0.96 (0.91–1.00) |